Chris Austin believes stakeholders will have to protect the coronavirus-inspired changes to the clinical trial system from an establishment longing to return to the status quo once the pandemic subsides.
The director of the US National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) said the pandemic has...







